Ratings by Brookline Capital Markets
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Kumaraguru Raja | Cellectar Biosciences | CLRB | New Coverage | Buy (N/A) |
15.00 (N/A) |
2.77 (2.51) |
-9.39% | Details |
| 6/29/2026 | Kumaraguru Raja | Edesa Biotech Inc. | EDSA | New Coverage | Buy (N/A) |
21.00 (N/A) |
8.19 (6.60) |
-19.41% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 298 more... | |||||||||
